Bamlanivimab
Generic Name: bamlanivimab
Dosage form: LIQUID. Active ingredients: BAMLANIVIMAB (5 kg/5kg). Category: BULK INGREDIENT.
Overview
Dosage form: LIQUID. Active ingredients: BAMLANIVIMAB (5 kg/5kg). Category: BULK INGREDIENT.
Dosage
Available as liquid.
Related Medications
Calendula Officinalis, Chamomilla, Echinacea Angustifolia, Eupatorium Perfoliatum, Hepar Sulphuris Calcareum, Sulphur, Ferrum Phosphoricum, Kali Muriaticum
calendula officinalis, chamomilla, echinacea angustifolia, eupatorium perfoliatum, hepar sulphuris calcareum, sulphur, ferrum phosphoricum, kali muriaticum
Purpose Purpose Reduces inflammation Hypersensitivity, irritability Weakness, aching body Aching pain, flu-like symptoms Hypersensitive to cold, chills Headache, symptoms of fever Symptoms of fever Glandular swellings, inflammation
Crofelemer
crofelemer
Antidiarrheal [EPC]
11 DESCRIPTION MYTESI (crofelemer) delayed-release tablets is an anti-diarrheal, enteric-coated drug product for oral administration. It contains 125 mg of crofelemer, a botanical drug substance that is derived from the red latex of Croton lechleri Müll. Arg. Crofelemer is an oligomeric proanthocyanidin mixture primarily composed of (+)–catechin, (–)–epicatechin, (+)–gallocatechin, and (–)–epigallocatechin monomer units linked in random sequence, as represented below.
Quercus Rubra
quercus rubra
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: QUERCUS RUBRA POLLEN (.001 g/mL). Category: BLA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.